Comparing the effectiveness of spironolactone solution with clindamycin solution in patients with acne
Phase 2
Recruiting
- Conditions
- Mild to moderate acne vulgaris.Acne vulgarisL70.0
- Registration Number
- IRCT20120524009844N12
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Mild to moderate acne vulgaris
Age 15 to 35 years
Exclusion Criteria
Allergy and sensitivity to the drugs used in the study
worsening of lesions
suffering from diseases that cause acne and medicinal acne
severe cases of acne (cases of nodules and cysts)
use of anti-acne treatment in the last 4 weeks
pregnancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method